BB, play the a game: Bharat Biotech’s Covaxin must play a far larger role in India’s vaccination drive. And get WHO approval

India’s truly atmanirbhar, made-by-Bharat Biotech (BB) vaccine, Covaxin, is yet to secure WHO’s Emergency Use Listing. This, when Sinovac became the second Chinese vaccine after Sinopharm to get global approval. Covaxin’s absence from the list...

from Times of India Opinion https://ift.tt/3vKZCsN